PlainPharmaWatch

CMS Open Payments · Program Year 2024

Nordic Pharma, Inc.

Nordic Pharma, Inc. reported $142,601.69 across General Payments, Research, and Ownership to 166 physicians and teaching hospitals across 166 transactions.

See the rankings → How this is sourced
$142.6K
All-tracks total
166
Transactions
166
Recipients
#1090
of 1,925 companies

Nordic Pharma, Inc. reported $142,601.69 across all CMS Open Payments tracks (General + Research + Ownership) to 166 physicians and teaching hospitals in Program Year 2024 - ranking #1090 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $142,601.69, averaging $859.05 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer nordic-pharma-inc Nordic Pharma, Inc.

$142.6K · #1090/1,925 · 0.0% industry · PY2024

  • TOT $142.6K
  • RANK #1090
  • SHARE 0.0%
  • TXN 166
  • RCP 166
  • CAT 3
  • GEN $142.6K
  • TOP1 12.1%
  • PY 2024

Volume peers

Nearest volume peer: Accuray Incorporated ($143.0K)

Accuray Incorporated$143.0KNordic Pharma, Inc. (this)$142.6KArchimmune Therapeutics Inc.$142.0KBeyond Air, Inc.$141.7KCeltic Biodevices LLC$141.4K
All-tracks payment totals near Nordic Pharma, Inc. (CMS Open Payments PY2024)

Nordic Pharma, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Nordic Pharma, Inc.

Rank #1090 of 1,925 companies in CMS Open Payments for 2024 belongs to Nordic Pharma, Inc., which reported $142,601.69 across 166 transactions to 166 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $859.05 per transaction and $859.05 per recipient.

Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $139.5K across 160 transactions, 97.8% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Nordic Pharma, Inc. made 3 types of general payments. "Consulting Fee" is the largest category at $139.5K, 97.8% of General Payments.

How Nordic Pharma, Inc. divides its payments

How the reported total splits across payment categories

1. Consulting Fee$139.5K2. Debt Forgiveness$2.1K3. Food and Beverage$1.0K
Payment Type Amount Transactions
Consulting Fee $139.5K 160
Debt Forgiveness $2.1K 3
Food and Beverage $1.0K 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $68,472.34 (48.0%) of $142,601.69 in this company's General Payments records across 21 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Nordic Pharma, Inc.

The five named recipients with the highest reported General Payments from this company

Mile Brujic$17.3KPaul Karpecki$14.4KEric Donnenfeld$13.1KDarrell White$12.2KSelina Mcgee$11.6K
  1. 1

    Mile Brujic

    $17,253.97 across 18 reported transactions

  2. 2

    Paul Karpecki

    $14,355.56 across 29 reported transactions

  3. 3

    Eric Donnenfeld

    $13,057.31 across 11 reported transactions

  4. 4

    Darrell White

    $12,178.70 across 12 reported transactions

  5. 5

    Selina Mcgee

    $11,626.80 across 8 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Nordic Pharma, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Nordic Pharma, Inc..

Neurent Medical Limited

HHI 699

Medexus Pharma, Inc.

HHI 698

Oticon Medical, LLC

HHI 706

BK Medical Holding Company Inc.

HHI 693

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Nordic Pharma, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Nordic Pharma, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.